Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Tags › Posts tagged Pharmaceutical Industry

Tag: Pharmaceutical Industry

Patients spent nearly $457 billion on prescription drugs, almost 8 percent more than in 2014. (Daniel Acker/Bloomberg) Healthcare

Spending on prescription drugs rose in 2015

Robert King · March 8, 2016 9:15 pm
"This right is strictly limited and can only be exercised if the agency conducts an investigation and determines that specific criteria are met," Burwell said. (Graeme Jennings/Examiner) Healthcare

Administration declines Dems’ attempt to bring down high drug prices

Robert King · March 7, 2016 9:17 pm
Sen. Charles Schumer, D-N.Y., center, accompanied by, from left, Sen. Jeanne Shaheen, D-N.H., Sen. Patty Murray, D-Wash., Sen. Joe Manchin, D-W.Va., Sen. Edward Markey, D-Mass., speak during a news conference on opioid and heroin abuse on Feb. 11 on Capitol Hill. (AP photo) Magazine

Manchin: Addiction should be bigger focus of FDA approval

Curt Mills · February 29, 2016 5:01 am
"Pfizer and other pharmaceutical companies can no longer be allowed to rip off American patients who already pay the highest prices in the world for prescription drugs," Bernie Sanders said. (AP Photo) Business

Sanders seizes on report that Pfizer will dodge $35 billion in taxes

Joseph Lawler · February 25, 2016 7:21 pm
The Senate voted 80-6 to advance the nomination of Dr. Robert Califf to a final vote, which will be held after 30 hours of debate. Califf needs a simple majority to be confirmed. (AP Photo) Healthcare

Senate tees up final vote for FDA nominee

Robert King · February 22, 2016 11:46 pm
Sens. Joe Manchin, center, and Ed Markey, right, are concerned about Dr. Robert Califf's ties to the drug industry. (Graeme Jennings/Washington Examiner) Healthcare

Dem senators start ‘uphill fight’ against FDA nominee

Robert King · February 22, 2016 7:40 pm
The number of federal lobbyists dropped 25 percent, but the number of state lobbyists grew 10 percent. (AP Photo/Haraz N. Ghanbari) Healthcare

Report: Lobbyists flocking from D.C. to state capitals

Anna Giaritelli · February 12, 2016 12:53 am
Rep. Orrin Hatch, R-Utah, is worried President Obama will issue an executive order to give Medicare the power to negotiate lower drug prices. (AP Photo/J. Scott Applewhite) Healthcare

Hatch slams possible Obama move on drug prices

Robert King · February 11, 2016 5:16 pm
Here are three recent problems and three possible solutions to the problem of money in politics. (AP Photo) Op-Eds

Three solutions for money in politics

Gary Shapiro · February 9, 2016 5:01 am
Super bowl drug ads made some sick Healthcare

Super bowl drug ads made some sick

Robert King · February 8, 2016 10:50 pm
Former drug company CEO Martin Shkreli said Rep. Trey Gowdy tried to "trick" him into talking at a House Oversight hearing. (AP Photos) Healthcare

Shkreli: Gowdy ‘conniving’ at hearing

Robert King · February 5, 2016 12:20 am
House Oversight and Reform Committee ranking member Rep. Elijah Cummings, D-Md., left, questions former Turing Pharmaceutical executive Martin Shkreli, who declined to answer questions because of a federal indictment on unrelated securities fraud charges. (AP Photo/Susan Walsh) Healthcare

Lavish lifestyles for drug execs unleash torrent of criticism

Robert King · February 4, 2016 7:34 pm
Advertisement
  • ‹Previous page
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • …
  • 142
  • ›Next page
Page 118 of 142
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement